LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 140 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.21 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $0 | – | 400 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 400 | -96.7% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 12,100 | -94.1% | 0.00% | -100.0% |
| Q3 2017 | $947,000 | +535.6% | 206,110 | +126.9% | 0.04% | +620.0% |
| Q2 2017 | $149,000 | +44.7% | 90,838 | -30.1% | 0.01% | +25.0% |
| Q1 2017 | $103,000 | -65.2% | 129,936 | +111.1% | 0.00% | -63.6% |
| Q4 2016 | $296,000 | -58.1% | 61,554 | -16.2% | 0.01% | -65.6% |
| Q3 2016 | $706,000 | +66.9% | 73,437 | +36.4% | 0.03% | +45.5% |
| Q2 2016 | $423,000 | -2.5% | 53,837 | -4.8% | 0.02% | -24.1% |
| Q1 2016 | $434,000 | +70.2% | 56,552 | +27.6% | 0.03% | +107.1% |
| Q4 2015 | $255,000 | – | 44,324 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $14,779,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $243,430,000 | 5.23% |
| BVF INC/IL | 10,963,000 | $37,493,000 | 1.48% |
| Integral Health Asset Management, LLC | 300,000 | $1,026,000 | 0.30% |
| NEA Management Company, LLC | 2,382,286 | $8,147,000 | 0.22% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $122,000 | 0.13% |
| PINNACLE ASSOCIATES LTD | 1,852,382 | $6,335,000 | 0.13% |
| XTX MARKETS LLC | 13,242 | $45,000 | 0.09% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 828,192 | $2,832,000 | 0.06% |
| WINTON GROUP Ltd | 192,890 | $660,000 | 0.05% |